The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Spatial transcriptomic analysis of tumor tissue from patients with metastatic urothelial carcinoma (mUC) receiving ipilimumab (IPI) plus nivolumab (Nivo) combined with sacituzumab govitecan (SG).
 
Faustine Ong
No Relationships to Disclose
 
Jin Xu
No Relationships to Disclose
 
Yonghong Zhang
No Relationships to Disclose
 
Monica Chatwal
Consulting or Advisory Role - Guidepoint Global; IntrinsiQ; Merck
Speakers' Bureau - Merck
 
Jus Chadha
Consulting or Advisory Role - Dendreon
Travel, Accommodations, Expenses - Dendreon
 
Youngchul Kim
No Relationships to Disclose
 
Carlos Segura
No Relationships to Disclose
 
Sean Yoder
No Relationships to Disclose
 
Gabriela Villeta-Astacio
No Relationships to Disclose
 
Douglas Marchion
No Relationships to Disclose
 
Jasreman Dhillon
No Relationships to Disclose
 
Jingsong Zhang
Honoraria - AstraZeneca/MedImmune; Dendreon; Sanofi
Consulting or Advisory Role - AstraZeneca/MedImmune; Dendreon; Sanofi
 
Jose Alejandro Guevara
No Relationships to Disclose
 
Xuefeng Wang
No Relationships to Disclose
 
Guru Sonpavde
Employment - Exact Sciences (I); Myriad Genetics (I)
Honoraria - Grand Rounds in Urology; Ideology Health; Onviv; PeerView; PrecisCa; UpToDate
Consulting or Advisory Role - Aktis Oncology; Astellas Pharma; Bicycle Therapeutics; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Ellipses Pharma; EMD Serono; Exelixis; G1 Therapeutics; Genentech; Gilead Sciences; Janssen; Kura Oncology; Loxo/Lilly; Loxo/Lilly; Lucence; Merck; Pfizer; Scholar Rock; Seagen; Syapse; Vial
Speakers' Bureau - Astellas Pharma; AVEO; Bayer; Exelixis; Gilead Sciences; INFORMAÇÃO BRASILEIRA DE ONCOLOGIA; Janssen Oncology; Medscape; Merck; Natera; Pfizer; Research to Practice; Seagen
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Gilead Sciences (Inst); Jazz Pharmaceuticals (Inst); Sumitomo Pharma Oncology (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb
Other Relationship - Bristol-Myers Squibb; Elsevier; G1 Therapeutics; Merck; Mereo BioPharma; QED Therapeutics
 
Rohit Jain
Honoraria - Curio Science; DAVA Oncology; FLASCO; MJH Life Sciences
Consulting or Advisory Role - AVEO; Bristol-Myers Squibb; EMD Serono; Gilead Sciences; Sanofi
Research Funding - Bristol Myers Squibb; Gilead Sciences; NCI
Travel, Accommodations, Expenses - Bristol Myers Squibb Foundation; DAVA Oncology; FLASCO; Sanofi